Postoperative complications are similar in glaucoma surgery

Article

Incidence of postoperative complications in eyes with primary angle-closure glaucoma (PACG) and primary open-angle glaucoma (POAG) are similar, according to a study published in Archives of Ophthalmology.

Incidence of postoperative complications in eyes with primary angle-closure glaucoma (PACG) and primary open-angle glaucoma (POAG) are similar, according to a study published in Archives of Ophthalmology.

Dr Tan Yar-Li et al., Singapore National Eye Centre and Singapore Eye Research Institute, Singapore, investigated the occurrence of postoperative complications and reoperations found in the first year after trabeculectomy and phacotrabeculectomy in eyes with PACG and POAG. The retrospective study looked at 446 patients with PACG and 816 POAG patients who underwent glaucoma operations at a Singapore hospital from January 2001 to December 2004.

Of the 446 subjects with PACG, 112 underwent trabeculectomy and 334 underwent phacotrabeculectomy. Phacotrabeculectomy was performed in 608 of the POAG subjects and 208 underwent trabeculectomy.

There was no significant difference between the POAG and PACG groups, but there was a higher incidence of postoperative complications in the trabeculectomy group compared with the phacotrabeculectomy group. The most frequent complications observed were hypotony with overfiltration, found in 23 cases, followed by 11 cases of bleb leak.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.